AS
Aakanksha Sawa
About Aakanksha Sawa
Data last updated:
Aakanksha Sawa is a Director at Althea Pharma Private Limited (since 2017), Director at Italic Techno Financial Consultants Private Limited (since 2020) and Director at Tater Fin-Vest Private Limited (since 2020), and holds 3 more current directorships. The companies operate in Pharma, Business Outsourcing and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹63.82 Cr; the largest is Althea Pharma Private Limited at ₹63.27 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Althea Pharma Private Limited U24232GJ2004PTC044200 | Director | 16 Oct 2017 | 2004 | ₹63.27 Cr (FY 2024) | Active |
 Italic Techno Financial Consultants Private Limited U74140MH1995PTC089936 | Director | 21 Sep 2020 | 1995 | ₹34.4 Lakh (FY 2025) | Active |
| Tater Fin-Vest Private Limited U65910MH1996PTC097111 | Director | 21 Sep 2020 | 1996 | ₹20.6 Lakh (FY 2025) | Active |
| Attalika Impex Private Limited U51900MH1992PTC068295 | Director | 21 Sep 2020 | 1992 | ₹8,054 (FY 2020) | Active |
| Aakanksha Securities Private Limited U65990MH1994PTC079492 | Director | 21 Sep 2020 | 1994 | Active | |
 Althea Unilife Llp AAK-7582 | Designated Partner | 04 Oct 2017 | 2017 | Active |
Board colleagues of Aakanksha Sawa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vaibhav Purnandu Jain | 02356297 | Althea Pharma Private Limited , Italic Techno Financial Consultants Private Limited and 4 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aakanksha Sawa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aakanksha Sawa
Aakanksha Sawa currently holds 6 directorships: Althea Pharma Private Limited (Director, since 16 Oct 2017, revenue ₹63.27 Cr (FY 2024)); Italic Techno Financial Consultants Private Limited (Director, since 21 Sep 2020, revenue ₹34.4 Lakh (FY 2025)); Tater Fin-Vest Private Limited (Director, since 21 Sep 2020, revenue ₹20.6 Lakh (FY 2025)); Attalika Impex Private Limited (Director, since 21 Sep 2020, revenue ₹8,054 (FY 2020)); Aakanksha Securities Private Limited (Director, since 21 Sep 2020); and 1 more.
Aakanksha Sawa was first appointed on 04 Oct 2017 as Designated Partner at Althea Unilife Llp. The most recent appointment on record is 21 Sep 2020 at Aakanksha Securities Private Limited.
The 4 current companies of Aakanksha Sawa that report revenue have a combined latest revenue of ₹63.82 Cr: Althea Pharma Private Limited ₹63.27 Cr (FY 2024); Italic Techno Financial Consultants Private Limited ₹34.4 Lakh (FY 2025); Tater Fin-Vest Private Limited ₹20.6 Lakh (FY 2025); Attalika Impex Private Limited ₹8,054 (FY 2020).
The current boards of Aakanksha Sawa's companies include Vaibhav Purnandu Jain (Althea Pharma Private Limited).